Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - DarioHealth Corp. | v430703_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - DarioHealth Corp. | v430703_ex31-2.htm |
| EX-4.22 - EXHIBIT 4.22 - DarioHealth Corp. | v430703_ex4-22.htm |
| EX-21.1 - EXHIBIT 21.1 - DarioHealth Corp. | v430703_ex21-1.htm |
| EX-32.1 - EXHIBIT 32.1 - DarioHealth Corp. | v430703_ex32-1.htm |
| EX-10.23 - EXHIBIT 10.23 - DarioHealth Corp. | v430703_ex10-23.htm |
| EX-10.17 - EXHIBIT 10.17 - DarioHealth Corp. | v430703_ex10-17.htm |
| 10-K - FORM 10-K - DarioHealth Corp. | v430703_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-1, No. 333-209002) of LabStyle Innovations Corp. (“LabStyle”) and in the related Prospectus of our report dated February 8, 2016, with respect to the consolidated financial statements of LabStyle included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
| Tel-Aviv, Israel | /s/ Kost Forer Gabbay & Kasierer |
| February 8, 2016 | A Member of Ernst & Young Global |